CERIBELL ($CBLL) posted quarterly earnings results for Q1 2026 on Monday, May 11th. The company reported earnings of -$0.52 per share, missing estimates of -$0.40 by $0.12. The company also reported revenue of $26,490,000, missing estimates of $26,610,147 by $-120,147.
You can see Quiver Quantitative's $CBLL stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CERIBELL Insider Trading Activity
CERIBELL insiders have traded $CBLL stock on the open market 65 times in the past 6 months. Of those trades, 0 have been purchases and 65 have been sales.
Here’s a breakdown of recent trading of $CBLL stock by insiders over the last 6 months:
- XINGJUAN CHAO (President and CEO) has made 0 purchases and 19 sales selling 337,084 shares for an estimated $6,331,418.
- JOSEF PARVIZI has made 0 purchases and 6 sales selling 100,000 shares for an estimated $2,121,762.
- RAYMOND WOO (Chief Technology Officer) has made 0 purchases and 18 sales selling 78,481 shares for an estimated $1,386,630.
- SCOTT BLUMBERG (Chief Financial Officer) has made 0 purchases and 4 sales selling 36,808 shares for an estimated $771,990.
- WILLIAM W BURKE has made 0 purchases and 2 sales selling 32,728 shares for an estimated $720,670.
- DAVID FOEHR (Senior VP, Finance and PAO) has made 0 purchases and 11 sales selling 22,287 shares for an estimated $433,328.
- REBECCA B ROBERTSON has made 0 purchases and 4 sales selling 9,154 shares for an estimated $183,231.
- JOSEPH S. MANNI (Chief Revenue Officer) sold 768 shares for an estimated $15,198
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
CERIBELL Hedge Fund Activity
We have seen 71 institutional investors add shares of CERIBELL stock to their portfolio, and 49 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- YU FAN removed 803,718 shares (-59.4%) from their portfolio in Q4 2025, for an estimated $17,625,535
- ABG-WTT GLOBAL LIFE SCIENCE CAPITAL PARTNERS GP LTD removed 646,281 shares (-59.4%) from their portfolio in Q4 2025, for an estimated $14,172,942
- FMR LLC removed 552,873 shares (-12.3%) from their portfolio in Q4 2025, for an estimated $12,124,504
- ROYCE & ASSOCIATES LP added 533,300 shares (+inf%) to their portfolio in Q4 2025, for an estimated $11,695,269
- CENTERBOOK PARTNERS LP removed 476,554 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $10,450,829
- MILLENNIUM MANAGEMENT LLC removed 467,747 shares (-70.2%) from their portfolio in Q4 2025, for an estimated $10,257,691
- SOLEUS CAPITAL MANAGEMENT, L.P. removed 360,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $7,894,800
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
CERIBELL Government Contracts
We have seen $1,141,300 of award payments to $CBLL over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- CERIBELL CLARITY EEG SUBSCRIPTION SERVICES: $1,072,500
- CLARITY CERIBELL EEG RECORDER LEASE: $68,800
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
CERIBELL Analyst Ratings
Wall Street analysts have issued reports on $CBLL in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 01/28/2026
To track analyst ratings and price targets for CERIBELL, check out Quiver Quantitative's $CBLL forecast page.
CERIBELL Price Targets
Multiple analysts have issued price targets for $CBLL recently. We have seen 2 analysts offer price targets for $CBLL in the last 6 months, with a median target of $30.0.
Here are some recent targets:
- Marie Thibault from BTIG set a target price of $30.0 on 01/28/2026
- William Plovanic from Canaccord Genuity set a target price of $30.0 on 12/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
